Rank | Gene Set | Z-score |
---|---|---|
1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.60840829 |
2 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.08168546 |
3 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.03805066 |
4 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.03805066 |
5 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.77871309 |
6 | detection of molecule of bacterial origin (GO:0032490) | 4.56454737 |
7 | macrophage activation involved in immune response (GO:0002281) | 4.53988035 |
8 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.50768594 |
9 | neutrophil activation involved in immune response (GO:0002283) | 4.33373481 |
10 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.32103621 |
11 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.28726060 |
12 | immunoglobulin mediated immune response (GO:0016064) | 4.19911698 |
13 | detection of other organism (GO:0098543) | 4.18984134 |
14 | microglial cell activation (GO:0001774) | 3.99559052 |
15 | myeloid dendritic cell activation (GO:0001773) | 3.98359180 |
16 | myeloid dendritic cell differentiation (GO:0043011) | 3.97423790 |
17 | detection of external biotic stimulus (GO:0098581) | 3.94760535 |
18 | positive regulation of interferon-alpha production (GO:0032727) | 3.92760368 |
19 | defense response to protozoan (GO:0042832) | 3.90417460 |
20 | regulation of interferon-alpha production (GO:0032647) | 3.89759791 |
21 | negative regulation of T cell mediated immunity (GO:0002710) | 3.87668219 |
22 | interferon-gamma production (GO:0032609) | 3.87211623 |
23 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.87132963 |
24 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.84957432 |
25 | negative thymic T cell selection (GO:0045060) | 3.82829803 |
26 | detection of bacterium (GO:0016045) | 3.81524818 |
27 | negative T cell selection (GO:0043383) | 3.79709620 |
28 | positive regulation of antigen processing and presentation (GO:0002579) | 3.79443234 |
29 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.74915281 |
30 | positive regulation of B cell differentiation (GO:0045579) | 3.67438804 |
31 | type I interferon signaling pathway (GO:0060337) | 3.65363612 |
32 | cellular response to type I interferon (GO:0071357) | 3.65363612 |
33 | macrophage activation (GO:0042116) | 3.63585299 |
34 | response to type I interferon (GO:0034340) | 3.63340360 |
35 | response to protozoan (GO:0001562) | 3.63116474 |
36 | response to peptidoglycan (GO:0032494) | 3.59410443 |
37 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.57436904 |
38 | negative regulation of cell killing (GO:0031342) | 3.57106178 |
39 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.57106178 |
40 | detection of biotic stimulus (GO:0009595) | 3.55998329 |
41 | mast cell activation (GO:0045576) | 3.55236568 |
42 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.54251832 |
43 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.51433979 |
44 | regulation of T cell tolerance induction (GO:0002664) | 3.50905697 |
45 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.48857912 |
46 | positive regulation by symbiont of host defense response (GO:0052509) | 3.45871336 |
47 | modulation by symbiont of host defense response (GO:0052031) | 3.45871336 |
48 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.45871336 |
49 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.45871336 |
50 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.45871336 |
51 | modulation by symbiont of host immune response (GO:0052553) | 3.45871336 |
52 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.45144614 |
53 | regulation of B cell differentiation (GO:0045577) | 3.43758444 |
54 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.41921158 |
55 | B cell mediated immunity (GO:0019724) | 3.40915183 |
56 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.40805557 |
57 | response to host immune response (GO:0052572) | 3.40805557 |
58 | tolerance induction (GO:0002507) | 3.40614123 |
59 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.39727159 |
60 | activated T cell proliferation (GO:0050798) | 3.39112374 |
61 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.37772076 |
62 | respiratory burst (GO:0045730) | 3.37452785 |
63 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.36257225 |
64 | neutrophil activation (GO:0042119) | 3.35636599 |
65 | leukocyte aggregation (GO:0070486) | 3.35436244 |
66 | regulation of antigen processing and presentation (GO:0002577) | 3.35074438 |
67 | regulation of gamma-delta T cell activation (GO:0046643) | 3.33123717 |
68 | regulation of regulatory T cell differentiation (GO:0045589) | 3.32928667 |
69 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.29390516 |
70 | NIK/NF-kappaB signaling (GO:0038061) | 3.28178600 |
71 | positive T cell selection (GO:0043368) | 3.27363716 |
72 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.26516808 |
73 | positive thymic T cell selection (GO:0045059) | 3.23572673 |
74 | dendritic cell differentiation (GO:0097028) | 3.22478720 |
75 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.21806247 |
76 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.21376300 |
77 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.20796448 |
78 | dendritic cell chemotaxis (GO:0002407) | 3.20625257 |
79 | T cell migration (GO:0072678) | 3.20500335 |
80 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.19405305 |
81 | granulocyte activation (GO:0036230) | 3.19196613 |
82 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.18259059 |
83 | positive regulation of macrophage differentiation (GO:0045651) | 3.17757131 |
84 | B cell receptor signaling pathway (GO:0050853) | 3.16735262 |
85 | dendritic cell migration (GO:0036336) | 3.13598977 |
86 | cellular response to interferon-beta (GO:0035458) | 3.12999383 |
87 | regulation of mast cell activation (GO:0033003) | 3.12558701 |
88 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.10087975 |
89 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.10087975 |
90 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.08149796 |
91 | response to interferon-beta (GO:0035456) | 3.07440369 |
92 | regulation of mast cell degranulation (GO:0043304) | 3.05866757 |
93 | cellular extravasation (GO:0045123) | 3.05762303 |
94 | regulation of hypersensitivity (GO:0002883) | 3.05579918 |
95 | response to muramyl dipeptide (GO:0032495) | 3.05393553 |
96 | response to interleukin-15 (GO:0070672) | 3.05049879 |
97 | positive regulation of defense response to virus by host (GO:0002230) | 3.04530848 |
98 | response to interferon-alpha (GO:0035455) | 3.04021221 |
99 | neutrophil mediated immunity (GO:0002446) | 3.03216086 |
100 | regulation of activation of Janus kinase activity (GO:0010533) | 3.03207383 |
101 | positive regulation of interleukin-12 production (GO:0032735) | 3.02570784 |
102 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.01942842 |
103 | response to host (GO:0075136) | 3.01942842 |
104 | response to host defenses (GO:0052200) | 3.01942842 |
105 | leukocyte degranulation (GO:0043299) | 3.01928955 |
106 | cellular response to interleukin-15 (GO:0071350) | 3.01221289 |
107 | positive regulation of isotype switching (GO:0045830) | 3.00186770 |
108 | negative regulation of interleukin-17 production (GO:0032700) | 2.98659220 |
109 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.97601477 |
110 | myeloid cell activation involved in immune response (GO:0002275) | 2.97552850 |
111 | positive regulation of interleukin-2 production (GO:0032743) | 2.97240277 |
112 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.97200001 |
113 | positive regulation of tolerance induction (GO:0002645) | 2.96631323 |
114 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.94093545 |
115 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.93418342 |
116 | positive regulation of B cell mediated immunity (GO:0002714) | 2.93418342 |
117 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.93243413 |
118 | T-helper 1 type immune response (GO:0042088) | 2.92326534 |
119 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.92018040 |
120 | thymic T cell selection (GO:0045061) | 2.90696034 |
121 | regulation of tolerance induction (GO:0002643) | 2.89672529 |
122 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.89446520 |
123 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.88779775 |
124 | negative regulation of adaptive immune response (GO:0002820) | 2.88549895 |
125 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.88346353 |
126 | myeloid leukocyte activation (GO:0002274) | 2.86950948 |
127 | positive regulation of interferon-beta production (GO:0032728) | 2.86643000 |
128 | T cell selection (GO:0045058) | 2.85865298 |
129 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.84500102 |
130 | negative regulation of B cell proliferation (GO:0030889) | 2.84054752 |
131 | positive regulation of mast cell activation (GO:0033005) | 2.83910255 |
132 | T cell activation involved in immune response (GO:0002286) | 2.83472518 |
133 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.83245214 |
134 | positive regulation of DNA recombination (GO:0045911) | 2.82638433 |
135 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.81255427 |
136 | mature B cell differentiation (GO:0002335) | 2.80590107 |
137 | negative regulation of interleukin-12 production (GO:0032695) | 2.79958753 |
138 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.79452767 |
139 | pinocytosis (GO:0006907) | 2.78871554 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.82747486 |
2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.53876858 |
3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.32883059 |
4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.76433795 |
5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.55300595 |
6 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.07914159 |
7 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.66660563 |
8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.60052299 |
9 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.52996105 |
10 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.34645789 |
11 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.34578096 |
12 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.25035876 |
13 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.21176469 |
14 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.11154697 |
15 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.05866179 |
16 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.79575812 |
17 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.66303223 |
18 | * MYB_26560356_Chip-Seq_TH2_Human | 2.59700334 |
19 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.58347683 |
20 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.52537079 |
21 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.47770673 |
22 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.46992203 |
23 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.39914524 |
24 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.35310596 |
25 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.31707315 |
26 | * MAF_26560356_Chip-Seq_TH1_Human | 2.23656475 |
27 | * MYB_26560356_Chip-Seq_TH1_Human | 2.13545747 |
28 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.07371064 |
29 | * VDR_21846776_ChIP-Seq_THP-1_Human | 2.06129233 |
30 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.04755457 |
31 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.03609298 |
32 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.99843336 |
33 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.99014330 |
34 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.98706829 |
35 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.97709395 |
36 | MYC_22102868_ChIP-Seq_BL_Human | 1.96605660 |
37 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.82008775 |
38 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.79523511 |
39 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.76727776 |
40 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.72179031 |
41 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.66915271 |
42 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.65980172 |
43 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.63717198 |
44 | SPI1_23127762_ChIP-Seq_K562_Human | 1.58919568 |
45 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.57114388 |
46 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.53959582 |
47 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51446447 |
48 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.48419743 |
49 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.48254967 |
50 | GATA1_22025678_ChIP-Seq_K562_Human | 1.46376049 |
51 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.43811378 |
52 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.43780987 |
53 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.40847125 |
54 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.36888009 |
55 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.36400371 |
56 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.35718790 |
57 | MAF_26560356_Chip-Seq_TH2_Human | 1.34788678 |
58 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.33706299 |
59 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.31556916 |
60 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.30981190 |
61 | GATA3_26560356_Chip-Seq_TH2_Human | 1.30634345 |
62 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.27315737 |
63 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.23549015 |
64 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.22599530 |
65 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.22270577 |
66 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.21390244 |
67 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.21245330 |
68 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.17357969 |
69 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.16557250 |
70 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.14089522 |
71 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.14021215 |
72 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.10898844 |
73 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.07476466 |
74 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.07468680 |
75 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.06202191 |
76 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05793136 |
77 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.05306743 |
78 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.05301327 |
79 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.04494408 |
80 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02553872 |
81 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.00896064 |
82 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.99941867 |
83 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.99460438 |
84 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.99341668 |
85 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.95206477 |
86 | GATA3_26560356_Chip-Seq_TH1_Human | 0.91207056 |
87 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.90973702 |
88 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.89639288 |
89 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.89326120 |
90 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.87262080 |
91 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.86221997 |
92 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.86161821 |
93 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.85668133 |
94 | GATA1_19941826_ChIP-Seq_K562_Human | 0.83804338 |
95 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.83080302 |
96 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.80051689 |
97 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.79710719 |
98 | GATA2_19941826_ChIP-Seq_K562_Human | 0.78015209 |
99 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.76525968 |
100 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.75905578 |
101 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.73326931 |
102 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.72473775 |
103 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.72295802 |
104 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.71767299 |
105 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.71562067 |
106 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.70725496 |
107 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.70499517 |
108 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.70035679 |
109 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.69779050 |
110 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.69100531 |
111 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.68807552 |
112 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.68186843 |
113 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.68170183 |
114 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.67682575 |
115 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.66823143 |
116 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.66771682 |
117 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.66672380 |
118 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.66577512 |
119 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.63520589 |
120 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.62617690 |
121 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.60748587 |
122 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.57928129 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 5.13440204 |
2 | MP0005671_abnormal_response_to | 3.81339991 |
3 | MP0009785_altered_susceptibility_to | 3.67033696 |
4 | MP0003436_decreased_susceptibility_to | 3.37285949 |
5 | MP0000685_abnormal_immune_system | 3.33090468 |
6 | MP0002148_abnormal_hypersensitivity_rea | 3.31463174 |
7 | MP0005000_abnormal_immune_tolerance | 3.22590490 |
8 | MP0005387_immune_system_phenotype | 3.18924838 |
9 | MP0001790_abnormal_immune_system | 3.18924838 |
10 | MP0001800_abnormal_humoral_immune | 3.04713324 |
11 | MP0005025_abnormal_response_to | 2.92952176 |
12 | * MP0002452_abnormal_antigen_presenting | 2.79349188 |
13 | * MP0002723_abnormal_immune_serum | 2.74518645 |
14 | * MP0002419_abnormal_innate_immunity | 2.74032304 |
15 | MP0003303_peritoneal_inflammation | 2.61581505 |
16 | MP0003724_increased_susceptibility_to | 2.60225956 |
17 | * MP0002420_abnormal_adaptive_immunity | 2.59032428 |
18 | * MP0001819_abnormal_immune_cell | 2.58266295 |
19 | MP0003763_abnormal_thymus_physiology | 2.44204388 |
20 | MP0002166_altered_tumor_susceptibility | 2.31786387 |
21 | MP0006082_CNS_inflammation | 2.29452825 |
22 | MP0002405_respiratory_system_inflammati | 2.25344107 |
23 | MP0002398_abnormal_bone_marrow | 2.19021406 |
24 | MP0009333_abnormal_splenocyte_physiolog | 2.18169278 |
25 | MP0001853_heart_inflammation | 2.11528579 |
26 | MP0000716_abnormal_immune_system | 2.10528588 |
27 | MP0002396_abnormal_hematopoietic_system | 2.05568393 |
28 | MP0005464_abnormal_platelet_physiology | 2.03714597 |
29 | MP0004510_myositis | 2.02907615 |
30 | MP0003300_gastrointestinal_ulcer | 2.00398434 |
31 | MP0010155_abnormal_intestine_physiology | 1.98894882 |
32 | MP0002006_tumorigenesis | 1.97818321 |
33 | MP0001845_abnormal_inflammatory_respons | 1.83701517 |
34 | MP0000689_abnormal_spleen_morphology | 1.82703724 |
35 | MP0001873_stomach_inflammation | 1.78443268 |
36 | MP0002722_abnormal_immune_system | 1.76231985 |
37 | MP0002429_abnormal_blood_cell | 1.73167018 |
38 | MP0005058_abnormal_lysosome_morphology | 1.72713685 |
39 | MP0005310_abnormal_salivary_gland | 1.69998607 |
40 | MP0001533_abnormal_skeleton_physiology | 1.62241352 |
41 | MP0004947_skin_inflammation | 1.57283241 |
42 | MP0004381_abnormal_hair_follicle | 1.56792590 |
43 | MP0000858_altered_metastatic_potential | 1.52091371 |
44 | MP0008469_abnormal_protein_level | 1.49540555 |
45 | MP0003448_altered_tumor_morphology | 1.48894143 |
46 | MP0005397_hematopoietic_system_phenotyp | 1.48583361 |
47 | MP0001545_abnormal_hematopoietic_system | 1.48583361 |
48 | MP0000703_abnormal_thymus_morphology | 1.46621513 |
49 | MP0002138_abnormal_hepatobiliary_system | 1.43842744 |
50 | MP0003866_abnormal_defecation | 1.41828373 |
51 | MP0000465_gastrointestinal_hemorrhage | 1.40752486 |
52 | MP0003191_abnormal_cellular_cholesterol | 1.36877496 |
53 | MP0005174_abnormal_tail_pigmentation | 1.35882397 |
54 | MP0004808_abnormal_hematopoietic_stem | 1.33995522 |
55 | MP0003172_abnormal_lysosome_physiology | 1.32451895 |
56 | MP0009840_abnormal_foam_cell | 1.30363579 |
57 | MP0000490_abnormal_crypts_of | 1.29878698 |
58 | MP0008057_abnormal_DNA_replication | 1.28441690 |
59 | MP0009764_decreased_sensitivity_to | 1.28394014 |
60 | MP0002933_joint_inflammation | 1.25958582 |
61 | MP0002277_abnormal_respiratory_mucosa | 1.24921442 |
62 | MP0008260_abnormal_autophagy | 1.23104059 |
63 | MP0004883_abnormal_blood_vessel | 1.19108597 |
64 | MP0000343_altered_response_to | 1.16587200 |
65 | MP0005451_abnormal_body_composition | 1.03672856 |
66 | MP0001348_abnormal_lacrimal_gland | 1.03632028 |
67 | MP0003075_altered_response_to | 1.02949085 |
68 | MP0008007_abnormal_cellular_replicative | 1.02755572 |
69 | MP0002998_abnormal_bone_remodeling | 1.01021238 |
70 | MP0003690_abnormal_glial_cell | 0.97526341 |
71 | MP0005164_abnormal_response_to | 0.97328185 |
72 | MP0009278_abnormal_bone_marrow | 0.96070346 |
73 | MP0005075_abnormal_melanosome_morpholog | 0.91883844 |
74 | MP0009763_increased_sensitivity_to | 0.90957203 |
75 | MP0010307_abnormal_tumor_latency | 0.90030607 |
76 | MP0003045_fibrosis | 0.88540567 |
77 | MP0003806_abnormal_nucleotide_metabolis | 0.88095382 |
78 | MP0002019_abnormal_tumor_incidence | 0.85894681 |
79 | MP0000015_abnormal_ear_pigmentation | 0.82647303 |
80 | MP0000604_amyloidosis | 0.81873622 |
81 | MP0003183_abnormal_peptide_metabolism | 0.75500267 |
82 | MP0000569_abnormal_digit_pigmentation | 0.74241628 |
83 | MP0005166_decreased_susceptibility_to | 0.73879497 |
84 | MP0002132_abnormal_respiratory_system | 0.73343000 |
85 | MP0001851_eye_inflammation | 0.72450109 |
86 | MP0002254_reproductive_system_inflammat | 0.70885993 |
87 | MP0000249_abnormal_blood_vessel | 0.70875381 |
88 | MP0002163_abnormal_gland_morphology | 0.69144888 |
89 | MP0001663_abnormal_digestive_system | 0.68130650 |
90 | MP0000371_diluted_coat_color | 0.68006019 |
91 | MP0005390_skeleton_phenotype | 0.67146188 |
92 | MP0003186_abnormal_redox_activity | 0.66122866 |
93 | MP0003195_calcinosis | 0.64296750 |
94 | MP0003828_pulmonary_edema | 0.64013638 |
95 | MP0008004_abnormal_stomach_pH | 0.63342393 |
96 | MP0004782_abnormal_surfactant_physiolog | 0.62810597 |
97 | MP0002095_abnormal_skin_pigmentation | 0.62402239 |
98 | MP0003787_abnormal_imprinting | 0.60480956 |
99 | MP0005076_abnormal_cell_differentiation | 0.58597917 |
100 | MP0008873_increased_physiological_sensi | 0.58244639 |
101 | MP0005167_abnormal_blood-brain_barrier | 0.57645665 |
102 | MP0002009_preneoplasia | 0.56577331 |
103 | MP0000920_abnormal_myelination | 0.55441602 |
104 | MP0003656_abnormal_erythrocyte_physiolo | 0.53593395 |
105 | MP0001986_abnormal_taste_sensitivity | 0.53067220 |
106 | MP0003795_abnormal_bone_structure | 0.52937793 |
107 | MP0009765_abnormal_xenobiotic_induced | 0.52044698 |
108 | MP0000609_abnormal_liver_physiology | 0.51941002 |
109 | MP0002136_abnormal_kidney_physiology | 0.51846991 |
110 | MP0002877_abnormal_melanocyte_morpholog | 0.48949970 |
111 | MP0004484_altered_response_of | 0.47413730 |
112 | MP0002693_abnormal_pancreas_physiology | 0.46099059 |
113 | MP0000313_abnormal_cell_death | 0.45820564 |
114 | MP0003252_abnormal_bile_duct | 0.45333170 |
115 | MP0003077_abnormal_cell_cycle | 0.45104205 |
116 | MP0003693_abnormal_embryo_hatching | 0.44997437 |
117 | MP0010352_gastrointestinal_tract_polyps | 0.44946788 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Recurrent abscess formation (HP:0002722) | 5.68159704 |
2 | Myositis (HP:0100614) | 5.65426880 |
3 | Eczematoid dermatitis (HP:0000976) | 5.18315601 |
4 | Recurrent bacterial skin infections (HP:0005406) | 5.02666476 |
5 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.95891928 |
6 | Retrobulbar optic neuritis (HP:0100654) | 4.75407058 |
7 | Optic neuritis (HP:0100653) | 4.75407058 |
8 | Orchitis (HP:0100796) | 4.56828161 |
9 | Recurrent fungal infections (HP:0002841) | 4.03028427 |
10 | Mediastinal lymphadenopathy (HP:0100721) | 3.94096367 |
11 | Recurrent viral infections (HP:0004429) | 3.85383734 |
12 | Abnormality of macrophages (HP:0004311) | 3.78265521 |
13 | Chronic otitis media (HP:0000389) | 3.76915570 |
14 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.76359269 |
15 | Abnormality of T cell number (HP:0011839) | 3.72532055 |
16 | Thrombocytosis (HP:0001894) | 3.70847611 |
17 | Chronic obstructive pulmonary disease (HP:0006510) | 3.69294089 |
18 | Obstructive lung disease (HP:0006536) | 3.69294089 |
19 | T lymphocytopenia (HP:0005403) | 3.66345695 |
20 | Recurrent skin infections (HP:0001581) | 3.59704503 |
21 | Vasculitis (HP:0002633) | 3.56560280 |
22 | Meningitis (HP:0001287) | 3.52599867 |
23 | Pulmonary infiltrates (HP:0002113) | 3.45807803 |
24 | Vacuolated lymphocytes (HP:0001922) | 3.42033114 |
25 | Stomatitis (HP:0010280) | 3.36398388 |
26 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.31356328 |
27 | Recurrent cutaneous fungal infections (HP:0011370) | 3.31356328 |
28 | Abnormality of T cells (HP:0002843) | 3.25934934 |
29 | Spontaneous hematomas (HP:0007420) | 3.23738299 |
30 | Systemic lupus erythematosus (HP:0002725) | 3.21943217 |
31 | Recurrent bronchitis (HP:0002837) | 3.20908401 |
32 | Keratoconjunctivitis sicca (HP:0001097) | 3.17607662 |
33 | IgM deficiency (HP:0002850) | 3.17349198 |
34 | Autoimmune thrombocytopenia (HP:0001973) | 3.14418005 |
35 | Arterial thrombosis (HP:0004420) | 3.13098846 |
36 | Hemoptysis (HP:0002105) | 3.08781632 |
37 | Panhypogammaglobulinemia (HP:0003139) | 3.01881476 |
38 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.98277789 |
39 | IgG deficiency (HP:0004315) | 2.94323262 |
40 | Nasal polyposis (HP:0100582) | 2.90945823 |
41 | Gastrointestinal infarctions (HP:0005244) | 2.87590366 |
42 | Abnormality of the prostate (HP:0008775) | 2.86611241 |
43 | Keratoconjunctivitis (HP:0001096) | 2.86538386 |
44 | Gingivitis (HP:0000230) | 2.85880009 |
45 | Abnormality of glycolipid metabolism (HP:0010969) | 2.84496251 |
46 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.84496251 |
47 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.84496251 |
48 | Encephalitis (HP:0002383) | 2.83944152 |
49 | Severe combined immunodeficiency (HP:0004430) | 2.83630628 |
50 | Basal ganglia calcification (HP:0002135) | 2.83602098 |
51 | Abnormality of T cell physiology (HP:0011840) | 2.83174331 |
52 | Inflammation of the large intestine (HP:0002037) | 2.82074372 |
53 | Pustule (HP:0200039) | 2.77359288 |
54 | Chronic diarrhea (HP:0002028) | 2.76073850 |
55 | Leukocytosis (HP:0001974) | 2.75583760 |
56 | Gastrointestinal inflammation (HP:0004386) | 2.71474272 |
57 | Eosinophilia (HP:0001880) | 2.70194499 |
58 | Thyroiditis (HP:0100646) | 2.69855375 |
59 | Increased IgM level (HP:0003496) | 2.69025804 |
60 | Combined immunodeficiency (HP:0005387) | 2.66742497 |
61 | Cellulitis (HP:0100658) | 2.65681423 |
62 | Abnormality of eosinophils (HP:0001879) | 2.64679483 |
63 | Abnormality of B cell number (HP:0010975) | 2.63845861 |
64 | B lymphocytopenia (HP:0010976) | 2.63845861 |
65 | Hypergammaglobulinemia (HP:0010702) | 2.61322215 |
66 | Chest pain (HP:0100749) | 2.60738726 |
67 | Periodontitis (HP:0000704) | 2.59219495 |
68 | Abnormality of the nasal mucosa (HP:0000433) | 2.54802203 |
69 | Glomerulonephritis (HP:0000099) | 2.52144215 |
70 | Polyneuropathy (HP:0001271) | 2.49978439 |
71 | Keratitis (HP:0000491) | 2.49893777 |
72 | Agammaglobulinemia (HP:0004432) | 2.48106678 |
73 | Granulocytopenia (HP:0001913) | 2.45671519 |
74 | Increased cerebral lipofuscin (HP:0011813) | 2.45077791 |
75 | Petechiae (HP:0000967) | 2.44615213 |
76 | Epistaxis (HP:0000421) | 2.44233628 |
77 | Gangrene (HP:0100758) | 2.43233464 |
78 | Gingival bleeding (HP:0000225) | 2.41259147 |
79 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.41064519 |
80 | Interstitial pulmonary disease (HP:0006530) | 2.40757479 |
81 | Disinhibition (HP:0000734) | 2.39812614 |
82 | Urticaria (HP:0001025) | 2.39740735 |
83 | Osteomyelitis (HP:0002754) | 2.38747247 |
84 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.36010941 |
85 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.34531608 |
86 | Colitis (HP:0002583) | 2.34250333 |
87 | Lymphopenia (HP:0001888) | 2.33558857 |
88 | Pulmonary embolism (HP:0002204) | 2.31829392 |
89 | Recurrent pneumonia (HP:0006532) | 2.27027026 |
90 | Episodic fever (HP:0001954) | 2.22591278 |
91 | Agnosia (HP:0010524) | 2.21233631 |
92 | Dysostosis multiplex (HP:0000943) | 2.20749435 |
93 | Vertigo (HP:0002321) | 2.20555274 |
94 | IgA deficiency (HP:0002720) | 2.20421709 |
95 | Glomerulopathy (HP:0100820) | 2.19631868 |
96 | Increased IgE level (HP:0003212) | 2.18130259 |
97 | Prolonged bleeding time (HP:0003010) | 2.17470363 |
98 | Hypochromic anemia (HP:0001931) | 2.15821710 |
99 | Abnormality of the endocardium (HP:0004306) | 2.14094171 |
100 | Anorexia (HP:0002039) | 2.14078147 |
101 | Abnormality of the pleura (HP:0002103) | 2.13703287 |
102 | Recurrent sinusitis (HP:0011108) | 2.13673482 |
103 | Lymphoma (HP:0002665) | 2.13528289 |
104 | Joint swelling (HP:0001386) | 2.12830654 |
105 | Amaurosis fugax (HP:0100576) | 2.12672790 |
106 | Autoimmune hemolytic anemia (HP:0001890) | 2.10077848 |
107 | Skin ulcer (HP:0200042) | 2.08239495 |
108 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.06311367 |
109 | Abnormality of the pericardium (HP:0001697) | 2.03870113 |
110 | Recurrent lower respiratory tract infections (HP:0002783) | 2.03711605 |
111 | Abnormality of the fingertips (HP:0001211) | 2.02447780 |
112 | Arthralgia (HP:0002829) | 1.98410041 |
113 | Hypochromic microcytic anemia (HP:0004840) | 1.97671811 |
114 | Thrombophlebitis (HP:0004418) | 1.97272605 |
115 | Amyloidosis (HP:0011034) | 1.95235949 |
116 | Acute hepatic failure (HP:0006554) | 1.91236877 |
117 | Sepsis (HP:0100806) | 1.89566051 |
118 | Restrictive lung disease (HP:0002091) | 1.89461776 |
119 | Premature loss of primary teeth (HP:0006323) | 1.88915927 |
120 | Skin rash (HP:0000988) | 1.88662035 |
121 | Hematochezia (HP:0002573) | 1.86956677 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TXK | 4.51609731 |
2 | MAP4K1 | 4.03737356 |
3 | MAP3K14 | 3.39665928 |
4 | TBK1 | 3.13889748 |
5 | TYK2 | 2.87366058 |
6 | IRAK4 | 2.81402735 |
7 | BLK | 2.79209952 |
8 | IKBKE | 2.74845341 |
9 | KIT | 2.71908954 |
10 | TEC | 2.55791194 |
11 | JAK3 | 2.54786451 |
12 | IKBKB | 2.52925831 |
13 | ZAP70 | 2.35101766 |
14 | IRAK3 | 2.16388564 |
15 | ITK | 2.10590563 |
16 | BTK | 2.05640164 |
17 | JAK1 | 2.04864633 |
18 | TAOK3 | 1.89898263 |
19 | PIM2 | 1.88650304 |
20 | TGFBR2 | 1.85252038 |
21 | SYK | 1.82212726 |
22 | RIPK4 | 1.72904353 |
23 | CSF1R | 1.67779742 |
24 | FGR | 1.54389230 |
25 | LCK | 1.49847597 |
26 | NME2 | 1.48841610 |
27 | HCK | 1.48176449 |
28 | STK10 | 1.46061325 |
29 | CHUK | 1.45075395 |
30 | CSK | 1.35268686 |
31 | FES | 1.31492232 |
32 | FGFR4 | 1.29377996 |
33 | PIM1 | 1.28306225 |
34 | LYN | 1.24774773 |
35 | MST4 | 1.21660993 |
36 | NLK | 1.20104827 |
37 | NEK9 | 1.19048883 |
38 | FLT3 | 1.14020994 |
39 | EPHB1 | 1.03808448 |
40 | MAP2K3 | 1.03121971 |
41 | SIK3 | 1.02743983 |
42 | FRK | 1.02427974 |
43 | STK24 | 1.02067323 |
44 | CLK1 | 1.01929150 |
45 | GRK6 | 0.99403607 |
46 | JAK2 | 0.98804836 |
47 | FGFR3 | 0.94821460 |
48 | PRPF4B | 0.90895266 |
49 | RPS6KA4 | 0.90811877 |
50 | IRAK2 | 0.90357776 |
51 | EEF2K | 0.89734221 |
52 | MAP3K12 | 0.88937514 |
53 | EIF2AK2 | 0.87429018 |
54 | TAOK1 | 0.84359839 |
55 | GRK7 | 0.83725459 |
56 | LRRK2 | 0.82864233 |
57 | MAP3K1 | 0.82860604 |
58 | MATK | 0.82496055 |
59 | PDK1 | 0.81492457 |
60 | MAP2K6 | 0.81061979 |
61 | RIPK1 | 0.79595534 |
62 | MAP3K13 | 0.78850245 |
63 | BMPR2 | 0.73736406 |
64 | ERN1 | 0.71616448 |
65 | TNIK | 0.70356139 |
66 | IRAK1 | 0.65755006 |
67 | MAPK7 | 0.63493993 |
68 | SCYL2 | 0.62966688 |
69 | PRKCQ | 0.61909560 |
70 | KDR | 0.61238562 |
71 | EPHA3 | 0.61223853 |
72 | MAPK12 | 0.60577748 |
73 | MAP3K11 | 0.59192789 |
74 | MAP3K10 | 0.57721766 |
75 | MAP3K2 | 0.56892381 |
76 | TRPM7 | 0.56875237 |
77 | CAMKK1 | 0.54203149 |
78 | YES1 | 0.54189869 |
79 | PTK2B | 0.53540005 |
80 | EIF2AK3 | 0.52821002 |
81 | CDK6 | 0.51830636 |
82 | MAP2K2 | 0.51334206 |
83 | CDK4 | 0.50323633 |
84 | ADRBK2 | 0.49544591 |
85 | ACVR1B | 0.49225325 |
86 | NUAK1 | 0.49107063 |
87 | MUSK | 0.48030990 |
88 | TNK2 | 0.47981520 |
89 | PRKCD | 0.47870692 |
90 | PDPK1 | 0.45701630 |
91 | ABL1 | 0.45269775 |
92 | GRK5 | 0.44218976 |
93 | STK4 | 0.43838381 |
94 | MAPKAPK2 | 0.41624559 |
95 | CAMKK2 | 0.39927061 |
96 | ABL2 | 0.39708838 |
97 | RPS6KA5 | 0.39611357 |
98 | CDC42BPA | 0.39363731 |
99 | MARK2 | 0.38920482 |
100 | SGK2 | 0.37892343 |
101 | TESK2 | 0.37630498 |
102 | CDK19 | 0.37390872 |
103 | SIK2 | 0.37206268 |
104 | MAP3K5 | 0.36772605 |
105 | KSR2 | 0.36698256 |
106 | EGFR | 0.36512595 |
107 | HIPK2 | 0.34728650 |
108 | RPS6KA6 | 0.34429142 |
109 | TGFBR1 | 0.34347275 |
110 | IGF1R | 0.33702606 |
111 | PIK3CG | 0.32589420 |
112 | MAPK4 | 0.32530864 |
113 | RAF1 | 0.29527018 |
114 | SGK3 | 0.29238663 |
115 | TLK1 | 0.28875743 |
116 | BRD4 | 0.28726240 |
117 | CDK9 | 0.28418174 |
118 | PAK4 | 0.28194980 |
119 | PINK1 | 0.27998940 |
120 | MAPK11 | 0.27222482 |
121 | STK11 | 0.26700104 |
122 | WNK1 | 0.25859279 |
123 | FYN | 0.25769215 |
124 | STK3 | 0.25768939 |
125 | ATR | 0.25755656 |
126 | DAPK2 | 0.24030318 |
127 | MAP3K3 | 0.23991870 |
128 | CAMK4 | 0.23936919 |
129 | MARK3 | 0.23683868 |
130 | MAP3K7 | 0.23655548 |
131 | RPS6KL1 | 0.20853417 |
132 | RPS6KC1 | 0.20853417 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Allograft rejection_Homo sapiens_hsa05330 | 3.51904686 |
2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.11530543 |
3 | Leishmaniasis_Homo sapiens_hsa05140 | 3.01466740 |
4 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.01051975 |
5 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.99895842 |
6 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.73473085 |
7 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.59809272 |
8 | Measles_Homo sapiens_hsa05162 | 2.52041032 |
9 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.52026836 |
10 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.38221882 |
11 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.38154786 |
12 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.26526443 |
13 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.21404794 |
14 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.19835501 |
15 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.17203111 |
16 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.14786444 |
17 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.94500395 |
18 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.83539831 |
19 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.83163765 |
20 | Pertussis_Homo sapiens_hsa05133 | 1.80289505 |
21 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.75504548 |
22 | Legionellosis_Homo sapiens_hsa05134 | 1.74988408 |
23 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.72872314 |
24 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.71596306 |
25 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.70259882 |
26 | Asthma_Homo sapiens_hsa05310 | 1.62183092 |
27 | Tuberculosis_Homo sapiens_hsa05152 | 1.59901273 |
28 | Malaria_Homo sapiens_hsa05144 | 1.55753651 |
29 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.54809940 |
30 | Influenza A_Homo sapiens_hsa05164 | 1.51165125 |
31 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.48677316 |
32 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.45657527 |
33 | Viral myocarditis_Homo sapiens_hsa05416 | 1.41706400 |
34 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.34814475 |
35 | Other glycan degradation_Homo sapiens_hsa00511 | 1.34682092 |
36 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.34572249 |
37 | Shigellosis_Homo sapiens_hsa05131 | 1.34111084 |
38 | Apoptosis_Homo sapiens_hsa04210 | 1.27487884 |
39 | Lysosome_Homo sapiens_hsa04142 | 1.26707771 |
40 | DNA replication_Homo sapiens_hsa03030 | 1.26063463 |
41 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.25534732 |
42 | Salmonella infection_Homo sapiens_hsa05132 | 1.21326852 |
43 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.15331340 |
44 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.14741735 |
45 | Hepatitis B_Homo sapiens_hsa05161 | 1.12982154 |
46 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.02948353 |
47 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.01809213 |
48 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.99331126 |
49 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.98881451 |
50 | Ribosome_Homo sapiens_hsa03010 | 0.97687681 |
51 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.96312891 |
52 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.91531514 |
53 | Base excision repair_Homo sapiens_hsa03410 | 0.88803132 |
54 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.84727788 |
55 | Phagosome_Homo sapiens_hsa04145 | 0.81494452 |
56 | Hepatitis C_Homo sapiens_hsa05160 | 0.78631109 |
57 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.77710548 |
58 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.77703043 |
59 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.72996080 |
60 | Platelet activation_Homo sapiens_hsa04611 | 0.68137854 |
61 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.67683770 |
62 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.66224129 |
63 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.64525661 |
64 | Mismatch repair_Homo sapiens_hsa03430 | 0.63123135 |
65 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.60716543 |
66 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.60159538 |
67 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.57144683 |
68 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.56954570 |
69 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.56610248 |
70 | HTLV-I infection_Homo sapiens_hsa05166 | 0.56518381 |
71 | Proteasome_Homo sapiens_hsa03050 | 0.54829954 |
72 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.54055555 |
73 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.51993146 |
74 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.50685330 |
75 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.48619343 |
76 | Homologous recombination_Homo sapiens_hsa03440 | 0.48267277 |
77 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.48232277 |
78 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.48096583 |
79 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.45621907 |
80 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.45103817 |
81 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.39963826 |
82 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.38663453 |
83 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.38221310 |
84 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.36943501 |
85 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.36893438 |
86 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.34988259 |
87 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.34534114 |
88 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.34452025 |
89 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.34339399 |
90 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.34099318 |
91 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.33958326 |
92 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.33688737 |
93 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.33451394 |
94 | Amoebiasis_Homo sapiens_hsa05146 | 0.31884935 |
95 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.31331428 |
96 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.31088289 |
97 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.29893097 |
98 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.29663546 |
99 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.28035065 |
100 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.27253954 |
101 | Endocytosis_Homo sapiens_hsa04144 | 0.27136721 |
102 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.26345208 |
103 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.26151078 |
104 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.24730524 |
105 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.23492602 |
106 | Spliceosome_Homo sapiens_hsa03040 | 0.23276768 |
107 | Insulin resistance_Homo sapiens_hsa04931 | 0.23105381 |
108 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.22319039 |
109 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.22250152 |
110 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.21852875 |
111 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.21222150 |
112 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.20916600 |
113 | Thyroid cancer_Homo sapiens_hsa05216 | 0.19636258 |
114 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.18870472 |
115 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.18815440 |
116 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.18550727 |
117 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.18008169 |
118 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.17773314 |
119 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.16996470 |
120 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.16576376 |
121 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.15724459 |
122 | Protein export_Homo sapiens_hsa03060 | 0.15206119 |
123 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.14998018 |
124 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.14741389 |
125 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.14225408 |